[go: up one dir, main page]

CN115536541A - Synthetic method of common intermediate of Freilaner and Afraner - Google Patents

Synthetic method of common intermediate of Freilaner and Afraner Download PDF

Info

Publication number
CN115536541A
CN115536541A CN202211252823.4A CN202211252823A CN115536541A CN 115536541 A CN115536541 A CN 115536541A CN 202211252823 A CN202211252823 A CN 202211252823A CN 115536541 A CN115536541 A CN 115536541A
Authority
CN
China
Prior art keywords
trifluoroethyl
acetamide
trifluoroethylamine
chloro
common intermediate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202211252823.4A
Other languages
Chinese (zh)
Inventor
彭要武
田文敬
叶青
徐建义
杨荣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Masteam Bio Tech Co ltd
Original Assignee
Masteam Bio Tech Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Masteam Bio Tech Co ltd filed Critical Masteam Bio Tech Co ltd
Priority to CN202211252823.4A priority Critical patent/CN115536541A/en
Publication of CN115536541A publication Critical patent/CN115536541A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/02Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/22Separation; Purification; Stabilisation; Use of additives
    • C07C231/24Separation; Purification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a synthetic method of a common intermediate of fluridone and alfilamide, belonging to the technical field of chemical synthesis. According to the invention, chloracetyl chloride and triethylamine are used as initial raw materials, 2-chloro-N- (2, 2-trifluoroethyl) acetamide is subjected to acylation reaction, then the 2-chloro-N- (2, 2-trifluoroethyl) acetamide is directly reacted with ammonia to obtain a crude product of 2-amino-N- (2, 2-trifluoroethyl) acetamide, and the crude product is subjected to reduced pressure distillation reaction to obtain a high-purity important intermediate 2-amino-N- (2, 2-trifluoroethyl) acetamide pure product.

Description

氟雷拉纳和阿福拉纳共同中间体的合成方法Synthetic method of common intermediate of Freilaner and Afraner

技术领域technical field

本发明属于化学合成技术领域,也属于兽药和医药原料药合成技术领域;特别涉及一种氟雷拉纳和阿福拉纳共同中间体的合成方法,具体为2-氨基-N-(2 ,2 ,2-三氟乙基)乙酰胺的合成方法。The invention belongs to the technical field of chemical synthesis, and also belongs to the technical field of synthesis of veterinary drugs and pharmaceutical raw materials; in particular, it relates to a method for synthesizing a common intermediate of Freilaner and Afraner, specifically 2-amino-N-(2, 2,2-trifluoroethyl) acetamide synthesis method.

背景技术Background technique

氟雷拉纳(英文名为:Fluralaner)和阿福拉纳(英文名为:Afoxolaner)都为异噁唑啉类杀虫剂与杀螨剂,通过作用于配体门控氯离子通道,尤其是抑制由神经递质γ-氨基丁酸(GABA)门控的通道,阻断氯离子从突触前膜到突触后膜的传递,导致昆虫神经元活性增加兴奋过度死亡。氟雷拉纳和阿福拉纳是一种广谱性杀虫剂,对蜱目、蚤目、虱目、半翅目和双翅目等害虫均具有良好的杀虫活性,其毒力高于或与常用杀虫剂相当。氟雷拉纳和阿福拉纳不仅与现有杀虫剂无显著的交互抗性,甚至对部分抗性害虫也具有较好的杀虫活性。中国农业部于2018年批准进口药物阿福拉纳米尔贝后咀嚼片作为用于治疗犬跳蚤、牌感染,同时预防犬心丝虫感染和/或治疗胃肠道线虫感染。另外,阿福拉纳也可以单独成药(尼可信,NexGard,阿福拉纳咀嚼片),是国内首个兼杀牌虫和跳蚤两种寄生虫的犬用口服驱虫药。氟雷拉纳主要用于治疗犬体表的跳蚤和蜱感染,还可辅助治疗因跳蚤引起的过敏性皮炎。氟雷拉纳作为一款为犬提供12周长效保护的抗跳蚤和蜱虫感染咀嚼片,该品仅需每12周给药一次,为宠物和宠物主人提供更便捷、高效的保障。氟雷拉纳于2014年1月首次在欧盟注册,默克公司首次以氟雷拉纳作为兽药Bravecto进行了商业化生产并于同年4月上市。Both Fluralaner (English name: Fluralaner) and Afoxolaner (English name: Afoxolaner) are isoxazoline insecticides and acaricides, which act on ligand-gated chloride ion channels, especially It inhibits the channel gated by the neurotransmitter γ-aminobutyric acid (GABA), blocks the transmission of chloride ions from the presynaptic membrane to the postsynaptic membrane, and leads to increased neuronal activity in insects, excessive excitation and death. Frellana and Afulaner are broad-spectrum insecticides with good insecticidal activity against pests such as ticks, fleas, lice, hemiptera and diptera, and their toxicity is high At or equivalent to commonly used insecticides. Frellana and Afulaner not only have no significant cross-resistance with existing insecticides, but even have good insecticidal activity against partially resistant pests. In 2018, the Ministry of Agriculture of the People's Republic of China approved the imported drug Avola Namilbe Chewable Tablets for the treatment of canine flea and card infection, as well as the prevention of canine heartworm infection and/or the treatment of gastrointestinal nematode infection. In addition, Aflana can also be made into medicine alone (NexGard, NexGard, Aflana chewable tablets), which is the first oral anthelmintic for dogs in China that kills both parasites and fleas. Frelaner is mainly used to treat flea and tick infestation on the surface of dogs, and can also assist in the treatment of allergic dermatitis caused by fleas. As a chewable tablet against flea and tick infection that provides long-term protection for dogs for 12 weeks, Frellanat only needs to be administered once every 12 weeks, providing pets and pet owners with more convenient and efficient protection. Frellana was registered in the European Union for the first time in January 2014, and Merck was the first to commercialize Frellana as a veterinary drug Bravecto and it went on the market in April of the same year.

鉴于氟雷拉纳和阿福拉纳是新型除虫兽药,有广阔的国内外市场前景,因此对氟雷拉纳和阿福拉纳共同的中间体关键片段的合成研究,可进一步提高和保障氟雷拉纳和阿福拉纳产品的质量,找到适合生产放大的生产工艺尤为重要,有利于降低原料药的生产成本。In view of the fact that Frellana and Afurana are new types of anthelmintic veterinary drugs and have broad domestic and foreign market prospects, the research on the synthesis of the key fragments of the common intermediates of Frellana and Afurana can further improve and guarantee It is particularly important to find a production process suitable for production scale-up for the quality of Freilaner and Afraner products, which will help reduce the production cost of APIs.

氟雷拉纳和阿福拉纳共同的中间体:2-氨基-N-(2 ,2 ,2-三氟乙基)乙酰胺。氟雷拉纳、阿福拉纳和共同中间体2-氨基-N-(2 ,2 ,2-三氟乙基)乙酰胺化学结构如下:The common intermediate of Freilaner and Afraner: 2-Amino-N-(2,2,2-trifluoroethyl)acetamide. The chemical structures of Frellaner, Afuraner and the common intermediate 2-amino-N-(2,2,2-trifluoroethyl)acetamide are as follows:

Figure DEST_PATH_IMAGE002AA
Figure DEST_PATH_IMAGE004AA
Figure DEST_PATH_IMAGE002AA
Figure DEST_PATH_IMAGE004AA

Figure DEST_PATH_IMAGE006AA
Figure DEST_PATH_IMAGE006AA

目前,国内外合成2-氨基-N-(2 ,2 ,2-三氟乙基)乙酰胺方法主要有三种:At present, there are three main methods for synthesizing 2-amino-N-(2,2,2-trifluoroethyl)acetamide at home and abroad:

1、以N-邻苯二甲酰甘氨酸起始物料,与三氟乙胺反应得到N-邻苯二甲酰亚氨基-N-(2 ,2 ,2-三氟乙基)乙酰胺,再与水合肼反应得到2-氨基-N-(2 ,2 ,2-三氟乙基)乙酰胺,工艺路线如下:1. With N-phthaloylglycine starting material, react with trifluoroethylamine to obtain N-phthalimido-N-(2,2,2-trifluoroethyl)acetamide, and then Reaction with hydrazine hydrate to obtain 2-amino-N-(2,2,2-trifluoroethyl)acetamide, the process route is as follows:

Figure DEST_PATH_IMAGE008A
Figure DEST_PATH_IMAGE008A

2、以氯乙酸和二苄胺为起始物料,两者反应完后得到N-二苄基甘氨酸,再与三氟乙胺反应得到2-二苄氨基-N-(2 ,2 ,2-三氟乙基)乙酰胺,再用Pd/C加氢的方法脱掉二苄基得到2-氨基-N-(2 ,2 ,2-三氟乙基)乙酰胺,工艺路线如下:2. Using chloroacetic acid and dibenzylamine as starting materials, after the reaction between the two, N-dibenzylglycine is obtained, and then reacted with trifluoroethylamine to obtain 2-dibenzylamino-N-(2,2,2- Trifluoroethyl) acetamide, then use the method of Pd/C hydrogenation to remove dibenzyl to obtain 2-amino-N-(2,2,2-trifluoroethyl) acetamide, the operational route is as follows:

Figure DEST_PATH_IMAGE010A
Figure DEST_PATH_IMAGE010A

3、以Boc-甘氨酸为起始物料,与三氟乙胺反应得到2-Boc-氨基-N-(2 ,2 ,2-三氟乙基)乙酰胺,再用HCl气体脱掉Boc保护基得到2-氨基-N-(2 ,2 ,2-三氟乙基)乙酰胺盐酸盐,工艺路线如下:3. Using Boc-glycine as the starting material, react with trifluoroethylamine to obtain 2-Boc-amino-N-(2,2,2-trifluoroethyl)acetamide, and then use HCl gas to remove the Boc protecting group Obtain 2-amino-N-(2,2,2-trifluoroethyl)acetamide hydrochloride, the operational route is as follows:

Figure DEST_PATH_IMAGE012A
Figure DEST_PATH_IMAGE012A

这三种方法都能得到2-氨基-N-(2 ,2 ,2-三氟乙基)乙酰胺,但是方法1中最后一步用到了管制品水合肼,而且会产生大量的难以除去的副产物邻苯二甲酰肼副产物;方法2中最后一步中用到了钯碳加氢工艺,不仅用到了贵重金属,成本较高,另外还有一定的工艺安全风险;方法3中以Boc-甘氨酸为起始物料,物料较贵,脱Boc保护基用到了HCl气体,成本较高;这3种方法都有一定的弊端,原子经济性较差,成本较高,都不太符合现有的绿色制造工艺要求,放大过程中都有一定的局限性,因此寻找一条高收率,原子经济性高成本低的工艺路线是很有必要的。These three methods can obtain 2-amino-N-(2,2,2-trifluoroethyl)acetamide, but the last step in method 1 uses the pipe product hydrazine hydrate, and will produce a large amount of side effects that are difficult to remove Product phthalic hydrazide by-product; used palladium carbon hydrogenation process in the last step in method 2, not only used precious metal, cost is higher, also has certain process safety risk in addition; In method 3, Boc-glycine As the starting material, the material is more expensive, HCl gas is used to remove the Boc protecting group, and the cost is high; these three methods have certain disadvantages, the atom economy is poor, and the cost is high, and they are not in line with the existing green The manufacturing process requirements and the amplification process have certain limitations, so it is necessary to find a process route with high yield, high atom economy and low cost.

发明内容Contents of the invention

本发明的目的就是用原子经济性高的工艺路线,高收率低成本得到合格的2-The purpose of the present invention is exactly to obtain qualified 2-

氨基-N-(2 ,2 ,2-三氟乙基)乙酰胺产品,有利于工业放大生产。所述方案如下:Amino-N-(2,2,2-trifluoroethyl)acetamide product is beneficial to industrial scale-up production. The scheme is as follows:

本发明实施例提供了一种氟雷拉纳和阿福拉纳共同中间体的合成方法,所述方法包括以下步骤:The embodiment of the present invention provides a method for synthesizing the common intermediate of Frellana and Afraner, the method comprising the following steps:

(1)将三氟乙胺或其盐溶于溶剂中,加入碱,于-20℃至30℃下滴加氯乙酰氯,经过酰化反应得到2-氯-N-(2 ,2 ,2-三氟乙基)乙酰胺,三氟乙胺或其盐与氯乙酰氯的摩尔比为1:0.8-2.0,碱与三氟乙胺或其盐的摩尔比为1:1-10。(1) Dissolve trifluoroethylamine or its salt in a solvent, add alkali, drop chloroacetyl chloride at -20°C to 30°C, and obtain 2-chloro-N-(2,2,2 - trifluoroethyl) acetamide, the molar ratio of trifluoroethylamine or its salt to chloroacetyl chloride is 1:0.8-2.0, the molar ratio of base to trifluoroethylamine or its salt is 1:1-10.

(2)2-氯-N-(2 ,2 ,2-三氟乙基)乙酰胺与氨于0℃至60℃下反应得到2-氨基-N-(2 ,2 ,2-三氟乙基)乙酰胺,2-氯-N-(2 ,2 ,2-三氟乙基)乙酰胺与氨的摩尔比为1:10-40。(2) 2-Chloro-N-(2,2,2-trifluoroethyl)acetamide reacts with ammonia at 0°C to 60°C to obtain 2-amino-N-(2,2,2-trifluoroethyl) Base) acetamide, the molar ratio of 2-chloro-N-(2,2,2-trifluoroethyl)acetamide to ammonia is 1:10-40.

本发明反应流程如下:The reaction process of the present invention is as follows:

Figure 107006DEST_PATH_IMAGE014
Figure 107006DEST_PATH_IMAGE014

其中,在步骤(1)中,三氟乙胺盐选自三氟乙胺盐酸盐、三氟乙胺硫酸盐、三氟乙胺磷酸盐或三氟乙胺对甲苯磺酸盐等,优选为三氟乙胺盐酸盐。Wherein, in step (1), the trifluoroethylamine salt is selected from trifluoroethylamine hydrochloride, trifluoroethylamine sulfate, trifluoroethylamine phosphate or trifluoroethylamine p-toluenesulfonate, etc., preferably For trifluoroethylamine hydrochloride.

其中,在步骤(1)中,溶剂选自水、二氯甲烷、甲基叔丁基醚、1,2-二氯乙烷、四氢呋喃、乙酸乙酯、正己烷和正庚烷等中的一种或两种的混合溶剂,优选为二氯甲烷。Wherein, in step (1), the solvent is selected from one of water, dichloromethane, methyl tert-butyl ether, 1,2-dichloroethane, tetrahydrofuran, ethyl acetate, n-hexane and n-heptane, etc. Or two mixed solvents, preferably dichloromethane.

其中,在步骤(1)中,溶剂与三氟乙胺的质量比为3-15:1。Wherein, in step (1), the mass ratio of solvent to trifluoroethylamine is 3-15:1.

其中,在步骤(1)中,碱选自碳酸钠、碳酸钾、碳酸氢钠、碳酸氢钾、氢氧化钠、氢氧化钾、三乙胺、吡啶或二异丙基乙胺等,优选为三乙胺。Wherein, in step (1), the base is selected from sodium carbonate, potassium carbonate, sodium bicarbonate, potassium bicarbonate, sodium hydroxide, potassium hydroxide, triethylamine, pyridine or diisopropylethylamine, etc., preferably triethylamine.

其中,在步骤(2)中,氨选自氨水、液氨、液氨甲醇溶液、液氨乙醇溶液或液氨四氢呋喃溶液等,优选为液氨甲醇溶液(甲醇作为溶剂)。Wherein, in step (2), ammonia is selected from ammonia water, liquid ammonia, liquid ammonia methanol solution, liquid ammonia ethanol solution or liquid ammonia tetrahydrofuran solution, etc., preferably liquid ammonia methanol solution (methanol is used as a solvent).

进一步地,在步骤(1)中,反应完成后加水(溶剂不为水),静置,取有机相;有机相用饱和碳酸氢钠洗pH至7-8,再用饱和氯化钠洗至中性,最后用无水硫酸钠干燥;过滤,浓缩掉溶剂得到粗品,粗品加入正己烷中并升温至52-60℃(优选为55℃)溶清,降温至5-15℃(优选为10℃),过滤和烘干得到2-氯-N-(2 ,2 ,2-三氟乙基)乙酰胺。Further, in step (1), after the reaction is completed, add water (the solvent is not water), let it stand, and take the organic phase; the organic phase is washed with saturated sodium bicarbonate to a pH of 7-8, and then washed with saturated sodium chloride to Neutral, and finally dried with anhydrous sodium sulfate; filtered, concentrated to remove the solvent to obtain the crude product, the crude product was added to n-hexane and heated to 52-60°C (preferably 55°C) to dissolve, and cooled to 5-15°C (preferably 10 ℃), filtered and dried to obtain 2-chloro-N-(2,2,2-trifluoroethyl)acetamide.

进一步地,在步骤(2)中,反应完成后减压蒸馏得到产品。Further, in step (2), the product is obtained by distillation under reduced pressure after the reaction is completed.

具体地,本发明提供的氟雷拉纳和阿福拉纳共同中间体的合成方法包括以下步骤:Specifically, the synthetic method of the common intermediate of Frellana and Afraner provided by the invention comprises the following steps:

(1)将三氟乙胺或其盐酸盐溶于二氯甲烷中,加入三乙胺,于-20℃至30℃下滴加氯乙酰氯,反应完成后加水,静置,取有机相;有机相用饱和碳酸氢钠洗pH至7-8,再用饱和氯化钠洗至中性,最后用无水硫酸钠干燥;过滤,浓缩掉溶剂得到粗品,粗品加入正己烷中并升温至52-60℃溶清,降温至5-15℃,过滤和烘干得到2-氯-N-(2 ,2 ,2-三氟乙基)乙酰胺;三氟乙胺或其盐酸盐与氯乙酰氯的摩尔比为1:0.8-2.0,三乙胺与三氟乙胺或其盐酸盐的摩尔比为1:1-10。(1) Dissolve trifluoroethylamine or its hydrochloride in dichloromethane, add triethylamine, add chloroacetyl chloride dropwise at -20°C to 30°C, add water after the reaction is completed, let stand, and take the organic phase The organic phase is washed with saturated sodium bicarbonate to pH 7-8, then washed with saturated sodium chloride to neutrality, and finally dried with anhydrous sodium sulfate; filtered, concentrated to remove the solvent to obtain a crude product, the crude product is added in n-hexane and heated to Dissolve at 52-60°C, lower the temperature to 5-15°C, filter and dry to obtain 2-chloro-N-(2,2,2-trifluoroethyl)acetamide; trifluoroethylamine or its hydrochloride and The molar ratio of chloroacetyl chloride is 1:0.8-2.0, and the molar ratio of triethylamine to trifluoroethylamine or its hydrochloride is 1:1-10.

(2)2-氯-N-(2 ,2 ,2-三氟乙基)乙酰胺与液氨甲醇溶液于0℃至60℃下反应,反应完成后减压蒸馏2-氨基-N-(2 ,2 ,2-三氟乙基)乙酰胺,2-氯-N-(2 ,2 ,2-三氟乙基)乙酰胺与液氨的摩尔比为1:10-40。(2) 2-Chloro-N-(2,2,2-trifluoroethyl)acetamide reacts with liquid ammonia methanol solution at 0°C to 60°C. After the reaction is completed, 2-amino-N-( 2,2,2-trifluoroethyl)acetamide, the molar ratio of 2-chloro-N-(2,2,2-trifluoroethyl)acetamide to liquid ammonia is 1:10-40.

本发明的优点是原子经济性非常高,创新点在于:三种基础原料氯乙酰氯、三氟乙胺、氨只掉了2分子HCl就合成出重要中间体2-氨基-N-(2 ,2 ,2-三氟乙基)乙酰胺,大大降低了后处理的成本和对环境的污染,符合绿色合成工艺理念,反应比较温和,利于工业生产放大。The advantage of the present invention is that the atom economy is very high, and the innovation point is that the important intermediate 2-amino-N-(2, 2,2-trifluoroethyl)acetamide greatly reduces post-processing cost and environmental pollution, conforms to the concept of green synthesis process, and has relatively mild reaction, which is beneficial to industrial production scale-up.

附图说明Description of drawings

图1是2-氯-N-(2 ,2 ,2-三氟乙基)乙酰胺的结晶产品GC谱图;Fig. 1 is the crystallization product GC spectrogram of 2-chloro-N-(2,2,2-trifluoroethyl)acetamide;

图2是2-氨-N-(2 ,2 ,2-三氟乙基)乙酰胺的反应液GC谱图;Fig. 2 is the reaction solution GC spectrogram of 2-amino-N-(2,2,2-trifluoroethyl)acetamide;

图3是2-氨-N-(2 ,2 ,2-三氟乙基)乙酰胺的减压蒸馏产品GC谱图。Fig. 3 is the GC spectrogram of the vacuum distillation product of 2-amino-N-(2,2,2-trifluoroethyl)acetamide.

具体实施方式detailed description

为使本发明的目的、技术方案和优点更加清楚,下面将结合附图对本发明作进一步地详细描述。In order to make the object, technical solution and advantages of the present invention clearer, the present invention will be further described in detail below in conjunction with the accompanying drawings.

实施例1 2-氯-N-(2 ,2 ,2-三氟乙基)乙酰胺的合成:Example 1 Synthesis of 2-chloro-N-(2,2,2-trifluoroethyl)acetamide:

在1L四口烧瓶中,称取360g二氯甲烷加入四口烧瓶中,按投料量称取57g三乙胺,加入47.6g 2,2,2-三氟乙胺加入溶剂中,氮气保护下,降温到-5℃-0℃,滴加60.8g氯乙酰氯和60g二氯甲烷混合液,T<0℃,滴加时间0.5-1h,滴加完毕后,转入至室温(25℃)反应3h,加入200g水,搅拌静置分液;水相用100ml二氯甲烷萃取,合并有机相。有机相用约200ml饱和碳酸氢钠洗pH至7-8,有机相再用100ml饱和氯化钠洗至中性。有机相加入无水硫酸钠干燥,过滤浓缩掉溶剂,得白色固体粗品81.7g。加入60g正己烷升温至55℃溶清。降温至10℃过滤,42℃烘干得白色固体产品68.9g,GC检测纯度99.1%,收率81.7%。In a 1L four-necked flask, weigh 360g of dichloromethane and add it to the four-necked flask, weigh 57g of triethylamine according to the feeding amount, add 47.6g of 2,2,2-trifluoroethylamine and add it to the solvent, under nitrogen protection, Cool down to -5°C-0°C, add dropwise a mixture of 60.8g chloroacetyl chloride and 60g methylene chloride, T<0°C, dropwise for 0.5-1h, after the dropwise addition, transfer to room temperature (25°C) for reaction 3h, add 200g of water, stir and stand still for liquid separation; the aqueous phase is extracted with 100ml of dichloromethane, and the organic phases are combined. The organic phase was washed with about 200 ml of saturated sodium bicarbonate to a pH of 7-8, and then the organic phase was washed with 100 ml of saturated sodium chloride until neutral. The organic phase was dried by adding anhydrous sodium sulfate, and the solvent was concentrated by filtration to obtain 81.7 g of a white solid crude product. Add 60g of n-hexane and heat up to 55°C to dissolve. The temperature was lowered to 10°C, filtered, and dried at 42°C to obtain 68.9 g of a white solid product with a purity of 99.1% and a yield of 81.7% as determined by GC.

实施例2 2-氨-N-(2 ,2 ,2-三氟乙基)乙酰胺的合成:Example 2 Synthesis of 2-amino-N-(2,2,2-trifluoroethyl)acetamide:

在2L的四口烧瓶中,加入800g氨水,50g 2-氯-N-(2 ,2 ,2-三氟乙基)乙酰胺加入氨水中,然后升温至50℃反应12h,反应完毕后,蒸掉大量的水,用二氯甲烷进行萃取,有机层合并后,蒸掉溶剂后,进行减压蒸馏,收集得到的馏分35.3 g,GC检测纯度99.1%,收率79.1%。In a 2L four-necked flask, add 800g of ammonia water, add 50g of 2-chloro-N-(2,2,2-trifluoroethyl)acetamide into the ammonia water, then raise the temperature to 50°C for 12 hours, after the reaction is completed, distill A large amount of water was removed, and extracted with dichloromethane. After the organic layers were combined, the solvent was evaporated, and then vacuum distillation was carried out to collect 35.3 g of fractions. The purity of GC was 99.1%, and the yield was 79.1%.

实施例3 2-氯-N-(2 ,2 ,2-三氟乙基)乙酰胺的合成:Example 3 Synthesis of 2-chloro-N-(2,2,2-trifluoroethyl)acetamide:

在2L四口烧瓶中,称取1200g二氯甲烷加入四口烧瓶中,按投料量称取222g三乙胺,加入136g 2,2,2-三氟乙胺盐酸盐加入溶剂中,氮气保护下,降温到-5℃-0℃,滴加124.3g氯乙酰氯和125g二氯甲烷混合液,T<0℃,滴加时间1h,滴加完毕后,转入至室温(25℃)反应3h,加入500g水,搅拌静置分液;水相用500ml二氯甲烷萃取,合并有机相。有机相用约400ml饱和碳酸氢钠洗pH至7-8,有机相再用400ml饱和氯化钠洗至中性。有机相加入无水硫酸钠干燥,过滤浓缩掉溶剂,得白色固体粗品168.8g。加入130g正己烷升温至55℃溶清。降温至10℃过滤,42℃烘干得白色固体产品129.9g,GC检测纯度99.6%,收率83.2%。In a 2L four-necked flask, weigh 1200g of dichloromethane and add it to the four-necked flask, weigh 222g of triethylamine according to the feeding amount, add 136g of 2,2,2-trifluoroethylamine hydrochloride into the solvent, and protect it under nitrogen Cool down to -5°C-0°C, add dropwise a mixture of 124.3g chloroacetyl chloride and 125g methylene chloride, T<0°C, dropwise for 1h, after the dropwise addition, transfer to room temperature (25°C) for reaction 3h, add 500g of water, stir and stand still for liquid separation; the aqueous phase is extracted with 500ml of dichloromethane, and the organic phases are combined. The organic phase was washed with about 400ml of saturated sodium bicarbonate to pH 7-8, and the organic phase was washed with 400ml of saturated sodium chloride until neutral. The organic phase was dried by adding anhydrous sodium sulfate, and the solvent was concentrated by filtration to obtain 168.8 g of a white solid crude product. Add 130g of n-hexane and heat up to 55°C to dissolve. The temperature was lowered to 10°C for filtration, and then dried at 42°C to obtain 129.9 g of a white solid product with a purity of 99.6% and a yield of 83.2% as determined by GC.

实施例4 2-氨-N-(2 ,2 ,2-三氟乙基)乙酰胺的合成:Example 4 Synthesis of 2-amino-N-(2,2,2-trifluoroethyl)acetamide:

在2L的四口烧瓶中,加入600g甲醇,降温至0℃,通入液氨大概300g左右,称取50g2-氯-N-(2 ,2 ,2-三氟乙基)乙酰胺加入甲醇氨溶液中,然后0-10℃反应12h,反应完毕后,蒸掉溶剂后进行减压蒸馏,收集得到的馏分36.5 g,GC检测纯度99.1%,收率82.1%。In a 2L four-neck flask, add 600g of methanol, cool down to 0°C, pass through about 300g of liquid ammonia, weigh 50g of 2-chloro-N-(2,2,2-trifluoroethyl)acetamide and add methanol ammonia solution, and then reacted at 0-10°C for 12 hours. After the reaction was completed, the solvent was evaporated and vacuum distillation was carried out to collect 36.5 g of the obtained fraction. The purity of GC was 99.1%, and the yield was 82.1%.

以上所述仅为本发明的较佳实施例,并不用以限制本发明,凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。The above descriptions are only preferred embodiments of the present invention, and are not intended to limit the present invention. Any modifications, equivalent replacements, improvements, etc. made within the spirit and principles of the present invention shall be included in the protection of the present invention. within range.

Claims (8)

1. A method for synthesizing a common intermediate of frataxin and afurat, the method comprising the steps of:
(1) Dissolving trifluoroethylamine or a salt thereof in a solvent, adding alkali, dropwise adding chloroacetyl chloride at a temperature of between 20 ℃ below zero and 30 ℃, and carrying out acylation reaction to obtain 2-chloro-N- (2, 2, 2-trifluoroethyl) acetamide, wherein the molar ratio of the trifluoroethylamine or the salt thereof to chloroacetyl chloride is 1:0.8-2.0, the molar ratio of the base to the trifluoroethylamine or the salt thereof is 1:1-10;
(2) Reacting 2-chloro-N- (2, 2, 2-trifluoroethyl) acetamide with ammonia at 0 ℃ to 60 ℃ to obtain 2-amino-N- (2, 2, 2-trifluoroethyl) acetamide, wherein the molar ratio of 2-chloro-N- (2, 2, 2-trifluoroethyl) acetamide to ammonia is 1:10-40.
2. The method for synthesizing a common intermediate of frataxin and afurana according to claim 1, wherein in step (1), the trifluoroethylamine salt is selected from trifluoroethylamine hydrochloride, trifluoroethylamine sulfate, trifluoroethylamine phosphate or trifluoroethylamine p-toluenesulfonate.
3. The method for synthesizing the common intermediate of frataxin and afurane according to claim 1, wherein in the step (1), the solvent is one or two of water, dichloromethane, methyl tert-butyl ether, 1, 2-dichloroethane, tetrahydrofuran, ethyl acetate, n-hexane and n-heptane.
4. The process for the synthesis of a common intermediate of frataxin and afurana according to claim 1, wherein in step (1), the base is selected from sodium carbonate, potassium carbonate, sodium bicarbonate, potassium bicarbonate, sodium hydroxide, potassium hydroxide, triethylamine, pyridine or diisopropylethylamine.
5. The method for synthesizing a common intermediate of frataxin and afurade according to claim 1, wherein in step (2), the ammonia is selected from ammonia water, liquid ammonia methanol solution, liquid ammonia ethanol solution or liquid ammonia tetrahydrofuran solution.
6. The method for synthesizing the common intermediate of the flurararina and the afurascen according to claim 1, wherein in the step (1), water is added after the reaction is completed, and the mixture is allowed to stand to obtain an organic phase; washing the organic phase with saturated sodium bicarbonate until the pH value is 7-8, then washing with saturated sodium chloride until the organic phase is neutral, and finally drying with anhydrous sodium sulfate; filtering, concentrating to remove solvent to obtain crude product, adding the crude product into N-hexane, heating to 52-60 deg.C for dissolving, cooling to 5-15 deg.C, filtering, and oven drying to obtain 2-chloro-N- (2, 2, 2-trifluoroethyl) acetamide.
7. The process for the synthesis of a common intermediate of frataxin and afurana according to claim 1, wherein in step (2), the product is obtained by distillation under reduced pressure after the reaction is completed.
8. The process for the synthesis of a common intermediate of flurararina and afurana according to claim 1, comprising the following steps:
(1) Dissolving trifluoroethylamine or hydrochloride thereof in dichloromethane, adding triethylamine, dropwise adding chloroacetyl chloride at the temperature of between 20 ℃ below zero and 30 ℃, adding water after the reaction is finished, standing, and taking an organic phase; washing the organic phase with saturated sodium bicarbonate until the pH value is 7-8, then washing with saturated sodium chloride until the organic phase is neutral, and finally drying with anhydrous sodium sulfate; filtering, concentrating to remove solvent to obtain crude product, adding the crude product into N-hexane, heating to 52-60 deg.C for dissolving, cooling to 5-15 deg.C, filtering, and oven drying to obtain 2-chloro-N- (2, 2, 2-trifluoroethyl) acetamide; the mol ratio of the trifluoroethylamine or the hydrochloride thereof to the chloroacetyl chloride is 1:0.8-2.0, the molar ratio of triethylamine to trifluoroethylamine or hydrochloride thereof is 1:1-10;
(2) Reacting 2-chloro-N- (2, 2, 2-trifluoroethyl) acetamide with liquid ammonia methanol solution at 0-60 ℃, and distilling the 2-amino-N- (2, 2, 2-trifluoroethyl) acetamide under reduced pressure after the reaction is finished, wherein the molar ratio of the 2-chloro-N- (2, 2, 2-trifluoroethyl) acetamide to the liquid ammonia is 1:10-40.
CN202211252823.4A 2022-10-13 2022-10-13 Synthetic method of common intermediate of Freilaner and Afraner Pending CN115536541A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202211252823.4A CN115536541A (en) 2022-10-13 2022-10-13 Synthetic method of common intermediate of Freilaner and Afraner

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202211252823.4A CN115536541A (en) 2022-10-13 2022-10-13 Synthetic method of common intermediate of Freilaner and Afraner

Publications (1)

Publication Number Publication Date
CN115536541A true CN115536541A (en) 2022-12-30

Family

ID=84733552

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202211252823.4A Pending CN115536541A (en) 2022-10-13 2022-10-13 Synthetic method of common intermediate of Freilaner and Afraner

Country Status (1)

Country Link
CN (1) CN115536541A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115772091A (en) * 2023-01-05 2023-03-10 济南久隆医药科技有限公司 Synthesis method of 2-amino-N- (2, 2-trifluoroethyl) acetamide

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009173621A (en) * 2007-10-29 2009-08-06 Nissan Chem Ind Ltd Method for producing 2-amino-n-(2,2,2,-trifluoroethyl)acetamide compound or salt thereof
US20130267729A1 (en) * 2010-09-27 2013-10-10 E.I. Du Pont De Nemours And Company Method for preparing 2-amino-n-(2,2,2-trifluoroethyl) acetamide
WO2020222158A1 (en) * 2019-04-30 2020-11-05 Hikal Limited Process for the preparation of 2-amino-n-(2,2,2-trifluoroethyl)-acetamide and salts thereof
CN114057594A (en) * 2020-07-31 2022-02-18 广东东阳光药业有限公司 Process for preparing 2-amino-N- (2,2, 2-trifluoroethyl) acetamide or its salt

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009173621A (en) * 2007-10-29 2009-08-06 Nissan Chem Ind Ltd Method for producing 2-amino-n-(2,2,2,-trifluoroethyl)acetamide compound or salt thereof
US20130267729A1 (en) * 2010-09-27 2013-10-10 E.I. Du Pont De Nemours And Company Method for preparing 2-amino-n-(2,2,2-trifluoroethyl) acetamide
WO2020222158A1 (en) * 2019-04-30 2020-11-05 Hikal Limited Process for the preparation of 2-amino-n-(2,2,2-trifluoroethyl)-acetamide and salts thereof
CN114057594A (en) * 2020-07-31 2022-02-18 广东东阳光药业有限公司 Process for preparing 2-amino-N- (2,2, 2-trifluoroethyl) acetamide or its salt

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115772091A (en) * 2023-01-05 2023-03-10 济南久隆医药科技有限公司 Synthesis method of 2-amino-N- (2, 2-trifluoroethyl) acetamide
CN115772091B (en) * 2023-01-05 2023-06-23 济南久隆医药科技有限公司 Synthesis method of 2-amino-N- (2, 2-trifluoroethyl) acetamide

Similar Documents

Publication Publication Date Title
KR101377778B1 (en) Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof
CN102036983B (en) Process for the preparation of 5-(2-amino-pyrimidin-4-yl)-2-aryl-1h-pyrrole-3-carboxamides
CN115536541A (en) Synthetic method of common intermediate of Freilaner and Afraner
CN103570633B (en) The preparation method of Gefitinib
CN106008283B (en) The preparation method of tauryl amine hydrochlorate
CN117586167A (en) A new synthesis process of fenfonitrile
CN101177428A (en) One-step synthesis method of tryptanthrin and its derivatives
CN108610290B (en) Preparation method of fluxapyroxad
Bhaskar et al. Synthesis analgesic, Anti-Inflammatory and antimicrobial activities of some 1-[5-(substituted phenyl)-4, 5-dihydro-1H-pyrazol-3-yl]-5-phenyl-1H-tetrazole
CN107417606B (en) Method and application for converting N-cyanomethylbis(trifluoromethyl)nicotinamide into flonicamid
CN102212032B (en) 5-hyroxyquinolone derivatives, and preparation method and application thereof
CN106957237B (en) A method of synthesis bromfenac sodium
CN111848546B (en) A kind of 2-(aminomethyl)thiazole-5-carbonitrile and its synthetic method
DE69009607T2 (en) 4,5,6,7-tetrasubstituted benzoxazolones.
CN111848527A (en) A kind of 4-chloro-2-(2-fluoro-4-methoxyphenyl)-6-methoxyquinazoline and its synthetic method
CN118047728B (en) Preparation method of fluororalrana
CN111423342A (en) Preparation method for co-production of N-methyl-2-fluoroaniline and crystalline sulfanilamide
CN116283926A (en) Preparation method of tandospirone citrate and application of tandospirone citrate in preparation
CN116730941B (en) 5-Phenyl-1, 3, 4-oxadiazole compound and preparation method and application thereof
Balenovic et al. Synthesis of Aminomethylglyoxal Derivatives
CN115819354A (en) A kind of synthetic method of alkyl substituted 6-alkyl-4-aminopyridazine or its salt
Bhaskar et al. SYNTHESIS ANALGESIC, ANTI-INFLAMMATORY AND ANTIMICROBIAL ACTIVITIES OF SOME 1-[5-(SUBSTITUTED PHENYL)-4, 5-DIHYDRO-1H-PYRAZOL-3-YL]-5-PHENYL-1H-TETRAZOLE
CN106083929B (en) A kind of tetrazolium phosphate compound and synthetic method with eelworm-killing activity
DE2625163A1 (en) ALPHA-CHLOROCARBON ACIDS AND THE PROCESS FOR THEIR PRODUCTION
JP2025506307A (en) Method for preparing nitrogen-containing heterocyclic compounds

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20221230

RJ01 Rejection of invention patent application after publication